Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N7FD
|
||||
| Former ID |
DIB003955
|
||||
| Drug Name |
Multi-epitope tyrosinase/gp100 vaccine
|
||||
| Synonyms |
Melanoma vaccine, Memorial Sloan-Kettering; Multi-epitope tyrosinase/gp100 vaccine (melanoma); Multi-epitope tyrosinase/gp100 vaccine (melanoma), Memorial Sloan-Kettering
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 2 | [1] | ||
| Company |
Memorial Sloan-Kettering Cancer Center
|
||||
| Target and Pathway | |||||
| Target(s) | Melanocytes lineage-specific antigen GP100 | Target Info | [1] | ||
| Tyrosine oxidase | Target Info | [1] | |||
| BioCyc Pathway | (S)-reticuline biosynthesis | ||||
| Eumelanin biosynthesis | |||||
| L-dopachrome biosynthesis | |||||
| KEGG Pathway | Tyrosine metabolism | ||||
| Riboflavin metabolism | |||||
| Metabolic pathways | |||||
| Melanogenesis | |||||
| PathWhiz Pathway | Riboflavin Metabolism | ||||
| Tyrosine Metabolism | |||||
| WikiPathways | Dopamine metabolism | ||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00003362) Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.